ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,527.20
      1.07%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      -2.20%
      Bitcoin
      67,924.61
      3.25%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Altimmune Inc (ALT)

      7. Altimmune Inc (ALT) Financials

      Altimmune Inc

      Altimmune Inc (ALT)

      Analytica Limited
      Altitude Group Plc
      Alturas Minerals Corp
      6.75
      0.06
      (0.90%)
      At close: July 26 4:00PM
      Delayed by 15 minutes
      6.78
      0.03
      ( 0.44% )
      After Hours: 6:58PM
      Delayed by 15 minutes

      Altimmune Inc Financial Summary

      The current ALT market cap is 480.72M. The company's latest EPS is USD -1.2475 and P/E is -5.41.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 21k6k362k37k5k
      Operating Income -21.76M-18.01M-22.54M-33.62M-26.79M
      Net Income -20.07M-16.06M-20.67M-31.64M-24.39M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 5.8M8.19M4.41M-68k426k
      Operating Income -20.47M-54.8M-85.92M-87.74M-95.93M
      Net Income -20.97M-49.04M-97.09M-84.71M-88.45M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 187.08M183.32M166.57M210.64M188.36M
      Total Liabilities 19.35M15.6M16.18M16.54M15.42M
      Total Equity 167.73M167.71M150.4M194.1M172.94M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 54.06M245.12M218.87M206.93M210.64M
      Total Liabilities 8.54M19.24M19.73M21.64M16.54M
      Total Equity 45.52M225.88M199.14M185.29M194.1M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -19.41M-38.79M-59.28M-75.81M-16.36M
      Investing 13.3M17.29M21.69M13.73M-39.52M
      Financing -302k12.76M13.35M86.11M-261k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -9.6M-34.44M-78.24M-62.59M-75.81M
      Investing -28.29M-72.1M87.52M-73.4M13.73M
      Financing 12.53M213.49M65.1M56.78M86.11M

      Stats and Ratios

      Market Cap 480.72M
      Price to Earnings Ratio -5.41
      Price to Sales Ratio 1.13k
      Price to Cash Ratio 3.54
      Price to Book Ratio 2.47
      Dividend Yield -

      Share Statistics

      Shares Outstanding 70.9M
      Average Volume (1 week) 2.23M
      Average Volume (1 Month) 3.11M
      52 Week Change 125.25%
      52 Week High 14.84
      52 Week Low 2.09
      Spread (Intraday) 0.04 (0.59%)

      Company Info

      Company Name Altimmune Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.altimmune.com
      Industry pharmaceutical preparations (2834)